BBB National Programs Newsroom

NAD Recommends Fillerina Skincare Products Discontinue Certain Product Performance Claims

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs, 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 9, 2020 – Following an inquiry by the National Advertising Division (NAD), initiated as part of its routine monitoring program, NAD determined that Qf Systems, LLC did not substantiate certain express and implied claims for Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film. Therefore, NAD recommended that the advertiser discontinue the claims “Boosted with a powerful blend of hyaluronic acids, this at-home skin care treatment fills in fine lines and wrinkles, revealing a more radiant complexion,” “Fillerina Dermo-Cosmetic Filler Treatment Grade 2 corrects visible wrinkles and expression lines” (and similar express claims) and the implied claim that Fillerina removes lines and wrinkles similar to cosmetic procedures. 

Fillerina Dermo-Cosmetic Replenishing Gel and the accompanying Nourishing Film are sold in containers which look like vials. Each treatment is applied by an instrument which looks like a syringe. NAD assessed the messages reasonably conveyed by the advertising and determined that images of the product vials and the accompanying syringe-like applicators alongside claims referring to the “filling in” or “plumping of wrinkles (including deep wrinkles)” and “adding volume to cheeks and lips,” reasonably convey the message that the products confer benefits similar to cosmetic procedures which are designed to “fill in” wrinkles and “lift” sagging skin. 

As support for its claims, the advertiser submitted a published study – the Nobile Study – conducted on Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film as well as the Fillerina day and night creams and the eye/lip cream. NAD appreciated that the Nobile Study was double-blinded, randomized, placebo-controlled, and employed a sufficiently large sample size and appropriate test population (subjects with mild to moderate wrinkling).    

However, NAD had concerns about other aspects of the study. NAD concluded that a two-week timeframe is not sufficient to determine any long-term benefits of the Replenishing Gel and Nourishing Film as touted on the Fillerina website (e.g., results will last for “up to 4 months”). Further, NAD noted that even if the effects reported in the study were shown to be statistically significant (which they were not), there is no evidence suggesting that the magnitude of these effects is noticeable by consumers, let alone consumer meaningful or to the degree reasonably implied by claims such as “fills in fine lines and wrinkles” or “corrects visible wrinkles and expression lines.” The units of measure for certain parameters are incredibly small (e.g., micrometers, cubic millimeters), and no context is provided as to how big a measurement difference must be for it to be perceived by the naked eye. 

For all these reasons, NAD determined that the Nobile Study was not a good fit for the challenged claims. However, NAD noted that nothing in its decision prevents the advertiser from making claims that match the results of the study—e.g., that Fillerina “improves the appearance of chrono-aged skin in subjects showing mild-to-moderate clinical signs of skin aging.”  

In its advertiser’s statement, Qf Systems stated that it will comply with NAD’s recommendations by making claims for Fillerina that match the results of the Nobile Study. Further, the advertiser stated that “in advertising Fillerina, QF Systems will refer to the results of Dr. Nobile’s study and in general to consumer satisfaction. With the will to comply with NAD recommendations, however, Qf Systems wants to stress its confidence in Fillerina products, supported by countless proofs of satisfaction from its users.” 

 

### 

 

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.     

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. This independent, non-profit organization enhances trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution, and accountability programs. BBB National Programs’ 10 leading industry self-regulation and dispute resolution programs resolve business issues of national and international importance, and fosters industry best practices in truth-in-advertising, child-directed marketing, data privacy, and dispute resolution. To learn more about industry self-regulation, visit bbbprograms.org.   

NAD Recommends Fillerina Skincare Products Discontinue Certain Product Performance Claims

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs, 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 9, 2020 – Following an inquiry by the National Advertising Division (NAD), initiated as part of its routine monitoring program, NAD determined that Qf Systems, LLC did not substantiate certain express and implied claims for Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film. Therefore, NAD recommended that the advertiser discontinue the claims “Boosted with a powerful blend of hyaluronic acids, this at-home skin care treatment fills in fine lines and wrinkles, revealing a more radiant complexion,” “Fillerina Dermo-Cosmetic Filler Treatment Grade 2 corrects visible wrinkles and expression lines” (and similar express claims) and the implied claim that Fillerina removes lines and wrinkles similar to cosmetic procedures. 

Fillerina Dermo-Cosmetic Replenishing Gel and the accompanying Nourishing Film are sold in containers which look like vials. Each treatment is applied by an instrument which looks like a syringe. NAD assessed the messages reasonably conveyed by the advertising and determined that images of the product vials and the accompanying syringe-like applicators alongside claims referring to the “filling in” or “plumping of wrinkles (including deep wrinkles)” and “adding volume to cheeks and lips,” reasonably convey the message that the products confer benefits similar to cosmetic procedures which are designed to “fill in” wrinkles and “lift” sagging skin. 

As support for its claims, the advertiser submitted a published study – the Nobile Study – conducted on Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film as well as the Fillerina day and night creams and the eye/lip cream. NAD appreciated that the Nobile Study was double-blinded, randomized, placebo-controlled, and employed a sufficiently large sample size and appropriate test population (subjects with mild to moderate wrinkling).    

However, NAD had concerns about other aspects of the study. NAD concluded that a two-week timeframe is not sufficient to determine any long-term benefits of the Replenishing Gel and Nourishing Film as touted on the Fillerina website (e.g., results will last for “up to 4 months”). Further, NAD noted that even if the effects reported in the study were shown to be statistically significant (which they were not), there is no evidence suggesting that the magnitude of these effects is noticeable by consumers, let alone consumer meaningful or to the degree reasonably implied by claims such as “fills in fine lines and wrinkles” or “corrects visible wrinkles and expression lines.” The units of measure for certain parameters are incredibly small (e.g., micrometers, cubic millimeters), and no context is provided as to how big a measurement difference must be for it to be perceived by the naked eye. 

For all these reasons, NAD determined that the Nobile Study was not a good fit for the challenged claims. However, NAD noted that nothing in its decision prevents the advertiser from making claims that match the results of the study—e.g., that Fillerina “improves the appearance of chrono-aged skin in subjects showing mild-to-moderate clinical signs of skin aging.”  

In its advertiser’s statement, Qf Systems stated that it will comply with NAD’s recommendations by making claims for Fillerina that match the results of the Nobile Study. Further, the advertiser stated that “in advertising Fillerina, QF Systems will refer to the results of Dr. Nobile’s study and in general to consumer satisfaction. With the will to comply with NAD recommendations, however, Qf Systems wants to stress its confidence in Fillerina products, supported by countless proofs of satisfaction from its users.” 

 

### 

 

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.     

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. This independent, non-profit organization enhances trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution, and accountability programs. BBB National Programs’ 10 leading industry self-regulation and dispute resolution programs resolve business issues of national and international importance, and fosters industry best practices in truth-in-advertising, child-directed marketing, data privacy, and dispute resolution. To learn more about industry self-regulation, visit bbbprograms.org.   

Blog

Enhancing Brand Safety: Understanding Self-Regulation vs. Independent Industry Self-Regulation

With copious amounts of content proliferating across a growing number of platforms and websites, it is an ongoing challenge for advertisers and platforms to ensure that digital ads are not placed next to harmful content. In this conversation, there is a key distinction few are making — the difference between ‘self-regulation’ and ‘independent, industry-wide self-regulation.’
Read more
Blog

CFBAI and CCAI Published the 2020 Annual Report on Participant Compliance and Program Progress

BBB National Programs has released the CFBAI and CCAI 2020 Annual Report, which includes findings on CFBAI and CCAI participant compliance with their commitment to advertise only foods that meet CFBAI’s strict Uniform Nutrition Criteria or to not engage in advertising primarily directed to children under age 12. The Report indicates excellent compliance by the 19 CFBAI participants and the eight CCAI participants in 2020.
Read more
Blog

What Do You Need to Know about the Florida Lemon Law?

If you have ever purchased or leased a car or SUV that you consider a lemon, you may have questions about the myriad of federal and state laws that govern your vehicle and the remedies available to you. Each state also has their own statute governing vehicles sold and leased in that state for personal use. Today, we look at the lemon law in Florida, one of the fastest-growing states in the U.S.
Read more
Blog

AI Can Be A Force For Good In Recruiting And Hiring New Employees

A challenge for rapid innovation in any industry is the ability for legal and regulatory requirements to keep pace. In the recruiting and hiring process, where AI provides aid to human decision-making and a welcome relief to managing a deluge of data, company leaders are asking themselves: How can we combine important technological innovation with a proactive approach to employment law requirements?
Read more

NAD Recommends Fillerina Skincare Products Discontinue Certain Product Performance Claims

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs, 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 9, 2020 – Following an inquiry by the National Advertising Division (NAD), initiated as part of its routine monitoring program, NAD determined that Qf Systems, LLC did not substantiate certain express and implied claims for Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film. Therefore, NAD recommended that the advertiser discontinue the claims “Boosted with a powerful blend of hyaluronic acids, this at-home skin care treatment fills in fine lines and wrinkles, revealing a more radiant complexion,” “Fillerina Dermo-Cosmetic Filler Treatment Grade 2 corrects visible wrinkles and expression lines” (and similar express claims) and the implied claim that Fillerina removes lines and wrinkles similar to cosmetic procedures. 

Fillerina Dermo-Cosmetic Replenishing Gel and the accompanying Nourishing Film are sold in containers which look like vials. Each treatment is applied by an instrument which looks like a syringe. NAD assessed the messages reasonably conveyed by the advertising and determined that images of the product vials and the accompanying syringe-like applicators alongside claims referring to the “filling in” or “plumping of wrinkles (including deep wrinkles)” and “adding volume to cheeks and lips,” reasonably convey the message that the products confer benefits similar to cosmetic procedures which are designed to “fill in” wrinkles and “lift” sagging skin. 

As support for its claims, the advertiser submitted a published study – the Nobile Study – conducted on Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film as well as the Fillerina day and night creams and the eye/lip cream. NAD appreciated that the Nobile Study was double-blinded, randomized, placebo-controlled, and employed a sufficiently large sample size and appropriate test population (subjects with mild to moderate wrinkling).    

However, NAD had concerns about other aspects of the study. NAD concluded that a two-week timeframe is not sufficient to determine any long-term benefits of the Replenishing Gel and Nourishing Film as touted on the Fillerina website (e.g., results will last for “up to 4 months”). Further, NAD noted that even if the effects reported in the study were shown to be statistically significant (which they were not), there is no evidence suggesting that the magnitude of these effects is noticeable by consumers, let alone consumer meaningful or to the degree reasonably implied by claims such as “fills in fine lines and wrinkles” or “corrects visible wrinkles and expression lines.” The units of measure for certain parameters are incredibly small (e.g., micrometers, cubic millimeters), and no context is provided as to how big a measurement difference must be for it to be perceived by the naked eye. 

For all these reasons, NAD determined that the Nobile Study was not a good fit for the challenged claims. However, NAD noted that nothing in its decision prevents the advertiser from making claims that match the results of the study—e.g., that Fillerina “improves the appearance of chrono-aged skin in subjects showing mild-to-moderate clinical signs of skin aging.”  

In its advertiser’s statement, Qf Systems stated that it will comply with NAD’s recommendations by making claims for Fillerina that match the results of the Nobile Study. Further, the advertiser stated that “in advertising Fillerina, QF Systems will refer to the results of Dr. Nobile’s study and in general to consumer satisfaction. With the will to comply with NAD recommendations, however, Qf Systems wants to stress its confidence in Fillerina products, supported by countless proofs of satisfaction from its users.” 

 

### 

 

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.     

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. This independent, non-profit organization enhances trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution, and accountability programs. BBB National Programs’ 10 leading industry self-regulation and dispute resolution programs resolve business issues of national and international importance, and fosters industry best practices in truth-in-advertising, child-directed marketing, data privacy, and dispute resolution. To learn more about industry self-regulation, visit bbbprograms.org.   

 

 

Media Inquiry